Brief: Zymeworks Q4 Operating Expenses USD 40.347 Million
06/03/2024 21:09
Mar 06 (Reuters) - Zymeworks Q4 pretax profit USD -19.204 million. * Q4 income from operations USD -23.421 million
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug